D. Boral Capital Maintains Buy on CervoMed, Maintains $31 Price Target

CervoMed Inc. 0.00%

CervoMed Inc.

CRVO

4.04

0.00%

D. Boral Capital analyst Jason Kolbert maintains CervoMed (NASDAQ: CRVO) with a Buy and maintains $31 price target.